Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorit Blickstein

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Israel Medical Association Journal : IMAJ|August 16, 2011
Long-term response to rituximab in patients with relapsing thrombotic thrombocytopenic purpuraGideon Y Stein, Dorit Blickstein, Jerome Orlin, et al.
The Israel Medical Association Journal : IMAJ|September 11, 2025
Persistent Challenges in Direct Oral Anticoagulant Prescriptions: Time to Optimize Medication Safety in Hospital and Community SettingsMajdi Masarwi, Hely Bassalov, Maya Koren-Michowitz, et al.
Annals of Hematology|June 2, 2026
Acquired hemophilia A following influenza vaccination: a case report and literature reviewDorit Blickstein, Talia Filipovich-Rimon, Osnat Garach-Jehoshua, et al.
Cancer Research|March 9, 2005
Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondriaRonit Rotem, Alina Heyfets, Orit Fingrut, et al.
The Israel Medical Association Journal : IMAJ|July 2, 2014
Acquired thrombasthenia due to inhibitory effect of glycoprotein IIbIIIa autoantibodiesDorit Blickstein, Rima Dardik, Esther Rosenthal, et al.
American Journal of Hematology|February 9, 2002
Detection of relapse in non-Hodgkin's lymphoma: role of routine follow-up studiesAvishay Elis, Dorit Blickstein, Osnat Klein, et al.
Journal of Thrombosis and Thrombolysis|September 5, 2020
Should patients treated with oral anti-coagulants be operated on within 48 h of hip fracture?Michal Shani, Rina Yahalom, Doron Comaneshter, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 21, 2018
Antiphospholipid syndrome characteristics and adverse pregnancy outcomes after 20 weeks of pregnancyRinat Gabbay-Benziv, Hadas Zafrir-Danieli, Dorit Blickstein, et al.
Renal Failure|May 16, 2014
Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumabHefziba Green, Emanuel Harari, Miriam Davidovits, et al.
Leukemia & Lymphoma|December 25, 2003
Serum CA 125 as a prognostic factor in non-Hodgkin's lymphomaOsnat Bairey, Dorit Blickstein, Pinhas Stark, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Israel Medical Association Journal : IMAJ|August 16, 2011
Long-term response to rituximab in patients with relapsing thrombotic thrombocytopenic purpuraGideon Y Stein, Dorit Blickstein, Jerome Orlin, et al.
The Israel Medical Association Journal : IMAJ|September 11, 2025
Persistent Challenges in Direct Oral Anticoagulant Prescriptions: Time to Optimize Medication Safety in Hospital and Community SettingsMajdi Masarwi, Hely Bassalov, Maya Koren-Michowitz, et al.
Annals of Hematology|June 2, 2026
Acquired hemophilia A following influenza vaccination: a case report and literature reviewDorit Blickstein, Talia Filipovich-Rimon, Osnat Garach-Jehoshua, et al.
Cancer Research|March 9, 2005
Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondriaRonit Rotem, Alina Heyfets, Orit Fingrut, et al.
The Israel Medical Association Journal : IMAJ|July 2, 2014
Acquired thrombasthenia due to inhibitory effect of glycoprotein IIbIIIa autoantibodiesDorit Blickstein, Rima Dardik, Esther Rosenthal, et al.
American Journal of Hematology|February 9, 2002
Detection of relapse in non-Hodgkin's lymphoma: role of routine follow-up studiesAvishay Elis, Dorit Blickstein, Osnat Klein, et al.
Journal of Thrombosis and Thrombolysis|September 5, 2020
Should patients treated with oral anti-coagulants be operated on within 48 h of hip fracture?Michal Shani, Rina Yahalom, Doron Comaneshter, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 21, 2018
Antiphospholipid syndrome characteristics and adverse pregnancy outcomes after 20 weeks of pregnancyRinat Gabbay-Benziv, Hadas Zafrir-Danieli, Dorit Blickstein, et al.
Renal Failure|May 16, 2014
Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumabHefziba Green, Emanuel Harari, Miriam Davidovits, et al.
Leukemia & Lymphoma|December 25, 2003
Serum CA 125 as a prognostic factor in non-Hodgkin's lymphomaOsnat Bairey, Dorit Blickstein, Pinhas Stark, et al.
Pageof 3